FDA 483 - Heartware, Inc. - September 30, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Heartware, Inc. in Miami Lakes, FL, was cited for significant deficiencies across its quality system, particularly in design control, corrective and preventive actions, complaint handling, and medical device reporting. These issues, many of which are repeat observations, led to numerous confirmed complaints, including patient deaths and serious injuries, related to the HVAD™ System's performance and reliability. The inspection highlights systemic failures in ensuring product safety, efficacy, and compliance with regulatory requirements.
ID · 8eccb497-c1b0-47d2-b89f-a87a3abad0a2